Nigeria: BUA Purchases 1m Doses of AstraZeneca Covid-19 Vaccines for Nigeria

Abdul Samad Rabiu, Chairman and CEO of the BUA Group in Nigeria
8 February 2021

*To be delivered next week *Pledges to buy additional 5m vaccines through BUA/CACOVID/AFREXIM partnership

BUA, one of Africa’s largest conglomerates, has paid for a million doses of AstraZeneca COVID-19 vaccines for Nigeria. They was made through the AFREXIM Vaccine programme in partnership with CACOVID.

This is coming at a time Nigeria, Africa’s most populous country, is experiencing a spike in COVID-19 cases.

These doses, expected to be delivered next week, will be the first delivery of vaccines to Nigeria since the COVID-19 vaccines became available and will be distributed to Nigerians at no cost.

A statement released Monday said BUA Founder, Abdul Samad Rabiu, thanked the President of the Afrexim Bank, Dr. Benedict Oramah for making the purchase possible and the Nigerian Central Bank Governor, Godwin Emefiele, for coordinating the process through the CACOVID Private Sector partnership.

“BUA decided to secure these 1million vaccines by paying the full amount for the vaccines today because these vaccines became available only last week through AFREXIM. We expect the vaccines to be delivered within the next 14 days and hope priority will be given to our frontline workers who have committed their lives to managing the pandemic,” Rabiu said.

He added that, “In addition to this, BUA is committing to purchase 5 million doses for Nigeria as soon as they become available through this same arrangement.”


AllAfrica publishes around 800 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.